First author Andrea Marzi, Ph.D., of NIAID's Laboratory of Virology, is shown in August 2014 analyzing Ebola test results from the ELWA3 hospital compound in Monrovia, Liberia.
View larger image.
Single Dose Ebola Vaccine: Safe, Effective in Monkeys against Outbreak Strain
NIH scientists report that a single dose of an experimental Ebola virus vaccine completely protects monkeys against the current outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior. The vaccine, VSV-EBOV, uses genetically engineered vesicular stomatitis virus to carry an EBOV gene that safely induces protective immunity. The experimental vaccine is currently undergoing testing in a global clinical trial in humans.